Related Experiment Videos
Supporting diabetes self-care in underserved populations: a randomized pilot study using medical assistant coaches
Laurie Ruggiero1, Ada Moadsiri1, Paula Butler2
1The University of Illinois at Chicago, School of Public Health, Chicago, Illinois (Dr Ruggiero, Ms Moadsiri)
The Diabetes Educator
|February 27, 2010
Summary
A medical assistant coach improved empowerment and reduced diabetes problems in a pilot study. While A1C levels didn't significantly change, this approach shows promise for type 2 diabetes management.
Area of Science:
- Endocrinology
- Public Health
- Health Services Research
Background:
- Type 2 diabetes disproportionately affects low-income minority populations.
- Effective self-care support is crucial for managing type 2 diabetes.
- Innovative care models are needed to address disparities in diabetes care.
Purpose of the Study:
- To evaluate an intervention using a certified medical assistant (CMA) with diabetes training.
- To assess the CMA's role within a multidisciplinary team for diabetes education and self-care support.
- To determine the impact of this intervention on low-income minority populations with type 2 diabetes.
Main Methods:
- A randomized controlled pilot study design was employed.
- Participants were randomized into a medical assistant coaching (MAC) group (N=25) or treatment as usual (TAU) group (N=25).
- A no-contact control (NCC) group (N=50) was included for comparison.
Main Results:
- No significant differences in A1C levels were found between the three groups, though a trend of decreasing A1C in the MAC group was observed.
- The MAC group showed significantly greater increases in perceived empowerment compared to the TAU group.
- The MAC group demonstrated a trend towards a larger reduction in perceived diabetes-related problems than the TAU group.
Conclusions:
- The inclusion of a medical assistant self-care coach shows promise for improving patient outcomes in type 2 diabetes care.
- This innovative role warrants further investigation in larger-scale studies.
- The findings suggest a potential for enhancing diabetes care delivery within existing multidisciplinary teams.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...